Skip to main content
Signal8

Cole Ryan

SEC insider (Form 3/4/5 filer). CIK 0002126966. Chief Operating Officer at Aurinia Pharmaceuticals Inc. (AUPH). 1 reported Form 4/5 transaction since Sep 2024; latest on May 18, 2026. Located in EDMONTON.

Companies Cole Ryan has filed insider reports for

  • Aurinia Pharmaceuticals Inc. (AUPH): Officer, Chief Operating Officer
Cole Ryan profile photo

Cole Ryan

CIK: 0002126966

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aurinia Pharmaceuticals Inc. logo
AUPH

Aurinia Pharmaceuticals Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    May 18, 2026
    Award
    Direct
    116.1K shares-

1-1 of 1